Yahoo Finance21 天
Pharvaris Presents Long-Term Clinical Data of Deucrictibant for the Prevention and ...
Reduced monthly HAE attack rate maintained for at least ... and acquired angioedema due to C1 inhibitor deficiency (AAE-C1INH), highlighted safety and efficacy data of deucrictibant, which is ...
Nasdaq20 天
Pharvaris Reports Sustained Reduction in HAE Attack Rates and Improved Quality of Life ...
The reduced monthly HAE attack rate was maintained for at least ... and acquired angioedema due to C1 inhibitor deficiency (AAE-C1INH), highlighted safety and efficacy data of deucrictibant ...